Summit Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$265K Sell
3,393
-260
-7% -$21K 0.04% 248
2026
Q1
$317K Buy
+3,653
New +$350K 0.05% 213

Other funds holding MDT

Summit Wealth Partners's MDT Position: Q2 2026 in Review

Summit Wealth Partners reduced its Medtronic (MDT) stake by 7.1% in Q2 2026, selling an estimated $21K and leaving 3,393 shares worth $265K. The position accounts for 0.04% of the portfolio, ranked #248.

Summit Wealth Partners first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. The position peaked at $317K in Q1 2026. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Summit Wealth Partners held 3,393 shares of Medtronic worth $265K as of Q2 2026.
  • Summit Wealth Partners sold 260 Medtronic shares in Q2 2026, an estimated $21K.
  • Medtronic made up 0.04% of Summit Wealth Partners's portfolio in Q2 2026, its #248 holding.
  • Summit Wealth Partners first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
  • Summit Wealth Partners's Medtronic position peaked at $317K in Q1 2026.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Summit Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.